These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2001755)

  • 1. Bone mineral density of the lumbar spine in women with endometriosis.
    Lane N; Baptista J; Orwoll E
    Fertil Steril; 1991 Mar; 55(3):537-42. PubMed ID: 2001755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density of the lumbar spine in endometriosis subjects compared to an age-similar control population.
    Lane N; Baptista J; Snow-Harter C
    J Clin Endocrinol Metab; 1991 Feb; 72(2):510-4. PubMed ID: 1825088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers.
    Laskey MA; Flaxman ME; Barber RW; Trafford S; Hayball MP; Lyttle KD; Crisp AJ; Compston JE
    Br J Radiol; 1991 Nov; 64(767):1023-9. PubMed ID: 1742583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women of reproductive age with endometriosis are not osteopenic.
    Ulrich U; Murano R; Skinner MA; Yin H; Chesnut CH
    Fertil Steril; 1998 May; 69(5):821-5. PubMed ID: 9591486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgically induced endometriosis attenuates accrual of bone mineral density in growing rats.
    Hearns-Stokes RM; Santoro NF; Simon JA
    Am J Obstet Gynecol; 2001 Feb; 184(3):331-5. PubMed ID: 11228482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel).
    Adamson GD; Heinrichs WL; Henzl MR; Yuzpe AA; Bergquist C; Jacobson JJ; Eriksson S; Kwei L; Gilbert SM
    Am J Obstet Gynecol; 1997 Dec; 177(6):1413-8. PubMed ID: 9423744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafarelin therapy in endometriosis: long-term effects on bone mineral density.
    Orwoll ES; Yuzpe AA; Burry KA; Heinrichs L; Buttram VC; Hornstein MD
    Am J Obstet Gynecol; 1994 Nov; 171(5):1221-5. PubMed ID: 7977523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.
    Takahashi Y; Minamitani K; Kobayashi Y; Minagawa M; Yasuda T; Niimi H
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1248-53. PubMed ID: 8772607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration.
    Taga M; Minaguchi H
    Acta Obstet Gynecol Scand; 1996 Feb; 75(2):162-5. PubMed ID: 8604604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
    Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis.
    Finkelstein JS; Arnold AL
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1214-9. PubMed ID: 10199756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis.
    Newhall-Perry K; Holloway L; Osburn L; Monroe SE; Heinrichs L; Henzl M; Marcus R
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):824-9. PubMed ID: 7573251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender disparity in BMD conversion: a comparison between Lunar and Hologic densitometers.
    Ganda K; Nguyen TV; Pocock N
    Arch Osteoporos; 2014; 9():180. PubMed ID: 25527404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results.
    Genant HK; Grampp S; Glüer CC; Faulkner KG; Jergas M; Engelke K; Hagiwara S; Van Kuijk C
    J Bone Miner Res; 1994 Oct; 9(10):1503-14. PubMed ID: 7817795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study.
    Hanley DA; Brown JP; Tenenhouse A; Olszynski WP; Ioannidis G; Berger C; Prior JC; Pickard L; Murray TM; Anastassiades T; Kirkland S; Joyce C; Joseph L; Papaioannou A; Jackson SA; Poliquin S; Adachi JD;
    J Bone Miner Res; 2003 Apr; 18(4):784-90. PubMed ID: 12674340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES; Judd HL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbar spine bone mineral density in diabetic children with recent onset.
    De Schepper J; Smitz J; Rosseneu S; Bollen P; Louis O
    Horm Res; 1998; 50(4):193-6. PubMed ID: 9838239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of spinal and femoral bone density by dual X-ray absorptiometry: comparison of lunar and hologic instruments.
    Pocock NA; Sambrook PN; Nguyen T; Kelly P; Freund J; Eisman JA
    J Bone Miner Res; 1992 Sep; 7(9):1081-4. PubMed ID: 1414500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of spine and hip BMD measurements in different DXA devices.
    Ozdemir A; Uçar M
    Eur J Radiol; 2007 Jun; 62(3):423-6. PubMed ID: 17289322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
    Finkelstein JS; Klibanski A; Arnold AL; Toth TL; Hornstein MD; Neer RM
    JAMA; 1998 Sep 23-30; 280(12):1067-73. PubMed ID: 9757854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.